Polyolefin compositions for photovoltaic encapsulant films

US12428507B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12428507-B2
Application numberUS-201716627202-A
CountryUS
Kind codeB2
Filing dateOct 31, 2017
Priority dateJun 29, 2017
Publication dateSep 30, 2025
Grant dateSep 30, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to an encapsulant film made from a curable composition comprising: (A) a polyolefin polymer; (B) an organic peroxide; (C) a silane coupling agent; and (D) a co-agent comprising a monocyclic organosiloxane of formula (I).

First claim

Opening claim text (preview).

What is claimed is: 1. A curable composition for forming an encapsulant film, wherein the composition comprises: a) from 85 wt % to 99.88 wt % of an ethylene/1-octene copolymer comprising of greater than 60 wt % ethylenic units and at least 30 wt % 1-octene units and having a density of from 0.870 g/cc to 0.890 (ASTM D792) and a melt index of from 1.0 g/10 min to 50.0 g/10 min (ASTM D1238, at 190° C./2.16 kg); b) from 0.1 wt % to 5 wt % of an organic peroxide; c) from 0.01 wt % to 2 wt % of a silane coupling agent; and d) from 0.01 wt % to 5 wt % of a co-agent comprising a monocyclic organosiloxane of formula (I): wherein subscript n is an integer greater than or equal to 3; each R 1 is independently a (C 2 -C 4 )alkenyl; and each R 2 is independently H, (C 1 -C 4 )alkyl, phenyl, or R 1 . 2. The composition of claim 1 , wherein the monocyclic organosiloxane of formula (I) is further described by any one of limitations (i) to (vi): (i) subscript n is 3; (ii) each R 1 is independently a (C 2 -C 3 )alkenyl; and each R 2 is independently H, (C 1 -C 2 )alkyl, or (C 2 -C 3 )alkenyl; (iii) each R 1 is vinyl; and each R 2 is independently (C 1 -C 2 )alkyl; (iv) each R 1 is vinyl; and each R 2 is methyl; (v) each R 1 is allyl; and each R 2 is independently (C 1 -C 2 )alkyl; (vi) each R 1 is allyl; and each R 2 is methyl. 3. The composition of claim 1 , wherein the monocyclic organosiloxane of formula (I) is further described by any one of limitations (i) to (vi): (i) subscript n is 4; (ii) each R 1 is independently a (C 2 -C 3 )alkenyl; and each R 2 is independently H, (C 1 -C 2 )alkyl, or (C 2 -C 3 )alkenyl; (iii) each R 1 is vinyl; and each R 2 is independently (C 1 -C 2 )alkyl; (iv) each R 1 is vinyl; and each R 2 is methyl; (v) each R 1 is allyl; and each R 2 is independently (C 1 -C 2 )alkyl; (vi) each R 1 is allyl; and each R 2 is methyl. 4. The composition of claim 1 , wherein the monocyclic organosiloxane of formula (I) is further described by any one of limitations (i) to (vi): (i) subscript n is 5 or 6; (ii) each R 1 is independently a (C 2 -C 3 )alkenyl; and each R 2 is independently H, (C 1 -C 2 )alkyl, or (C 2 -C 3 )alkenyl; (iii) each R 1 is vinyl; and each R 2 is independently (C 1 -C 2 )alkyl; (iv) each R 1 is vinyl; and each R 2 is methyl; (v) each R 1 is allyl; and each R 2 is independently (C 1 -C 2 )alkyl; (vi) each R 1 is allyl; and each R 2 is methyl. 5. The composition of claim 1 , wherein the monocyclic organosiloxane of formula (I) is selected from the group consisting of: 1,3,5,7-tetravinyl-1,3,5,7-tetramethylcyclotetrasiloxane; 1,3,5-trivinyl-1,3,5-trimethylcyclotrisiloxane; 1,3,5,7,9-pentavinyl-1,3,5,7,9-pentamethylcyclopentasiloxane; and combinations thereof. 6. An encapsulant film comprising a crosslinked polymeric composition comprising the reaction product of: a) from 85 wt % to 99.88 wt % of an ethylene/1-octene copolymer comprising of greater than 60 wt % of ethylenic units and at least 30 wt % 1-octene units and having a density of from 0.870 g/cc to 0.890 g/cc (ASTM D792) and a melt index of from 1.0 g/10 min to 50.0 g/10 min (ASTM D1238, at 190° C./2.16 kg); b) from 0.1 wt % to 5 wt % of an organic peroxide; c) from 0.01 wt % to 2 wt % of a silane coupling agent; and d) from 0.01 wt % to 5 wt % of a co-agent comprising a monocyclic organosiloxane of formula (I): wherein subscript n is an integer greater than or equal to 3; each R 1 is independently a (C 2 -C 4 )alkenyl; and each R 2 is independently H, (C 1 -C 4 )alkyl, phenyl, or R 1 ; and an average initial glass adhesion of greater than 60 N/cm. 7. The encapsulant film of claim 6 , wherein the monocyclic organosiloxane of formula (I) is further described by any one of limitations (i) to (vi): (i) subscript nis 3; (ii) each R 1 is independently a (C 2 -C 3 )alkenyl; and each R 2 is independently H, (C 1 -C 2 )alkyl, or (C 2 -C 3 )alkenyl; (iii) each R 1 is vinyl; and each R 2 is independently (C 1 -C 2 )alkyl; (iv) each R 1 is vinyl; and each R 2 is methyl; (v) each R 1 is allyl; and each R 2 is independently (C 1 -C 2 )alkyl; (vi) each R 1 is allyl; and each R 2 is methyl. 8. The encapsulant film of claim 6 , wherein the monocyclic organosiloxane of formula (I) is further described by any one of limitations (i) to (vi): (i) subscript n is 4; (ii) each R 1 is independently a (C 2 -C 3 )alkenyl; and each R 2 is independently H, (C 1 -C 2 )alkyl, or (C 2 -C 3 )alkenyl; (iii) each R 1 is vinyl; and each R 2 is independently (C 1 -C 2 )alkyl; (iv) each R 1 is vinyl; and each R 2 is methyl; (v) each R 1 is allyl; and each R 2 is independently (C 1 -C 2 )alkyl; (vi) each R 1 is allyl; and each R 2 is methyl. 9. The encapsulant film of claim 6 , wherein the monocyclic organosiloxane of formula (I) is further described by any one of limitations (i) to (vi): (i) subscript n is 5 or 6; (ii) each R 1 is independently a (C 2 -C 3 )alkenyl; and each R 2 is independently H, (C 1 -C 2 )alkyl, or (C 2 -C 3 )alkenyl; (iii) each R 1 is vinyl; and each R 2 is independently (C 1 -C 2 )alkyl; (iv) each R 1 is vinyl; and each R 2 is methyl; (v) each R 1 is allyl; and each R 2 is independently (C 1 -C 2 )alkyl; (vi) each R 1 is allyl; and each R 2 is methyl. 10. The encapsulant film of claim 6 , wherein the monocyclic organosiloxane of formula (I) is selected from the group consisting of: 1,3,5,7-tetravinyl-1,3,5,7-tetramethylcyclotetrasiloxane; 1,3,5-trivinyl-1,3,5-trimethylcyclotrisiloxane; 1,3,5,7,9-pentavinyl-1,3,5,7,9-pentamethylcyclopentasiloxane; and combinations thereof. 11. The encapsulant film of claim 6 , further comprising a volume resistivity of greater than 1.0*10 14 ohm-cm at room temperature. 12. The encapsulant film of claim 6 , further comprising a volume resistivity of greater than 1.0*10 14 ohm-cm at 60° C. 13. An electronic device module comprising: an electronic device, a cover sheet, and the encapsulant film of claim 6 .

Assignees

Inventors

Classifications

  • Materials of encapsulations · CPC title

  • containing silicon in a ring · CPC title

  • containing at least one C=C bond · CPC title

  • Homopolymers or copolymers of ethene · CPC title

  • Polyethylene · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12428507B2 cover?
The present disclosure relates to an encapsulant film made from a curable composition comprising: (A) a polyolefin polymer; (B) an organic peroxide; (C) a silane coupling agent; and (D) a co-agent comprising a monocyclic organosiloxane of formula (I).
Who is the assignee on this patent?
Dow Global Technologies Llc
What technology area does this patent fall under?
Primary CPC classification C08J3/24. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).